EWTX
Edgewise Therapeutics, Inc. · Healthcare
General Counsel John R Moore sold $46K of Edgewise Therapeutics, Inc.
Sold$46,155
$9.76Price
4,730Shares
−61%Stake
What EWTX did after the filing
- The stock from Wed, Oct 5 close, $10.66
- −6.4%
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Nov 16 close.
Traded Mon, Oct 3. Filed Wed, Oct 5, 12:42 PM ET, during the session. Returns use the Oct 5 close and the Nov 16 close. Not investment advice.